J. Safra Sarasin Holding’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$112M Buy
379,013
+2,408
+0.6% +$715K 1.91% 9
2025
Q4
$103M Sell
376,605
-61,065
-14% -$16.6M 1.67% 10
2025
Q3
$118M Sell
437,670
-50,272
-10% -$13.7M 1.91% 6
2025
Q2
$134M Sell
487,942
-2,828
-0.6% -$769K 2.32% 5
2025
Q1
$130M Buy
490,770
+40,012
+9% +$9.87M 2.36% 4
2024
Q4
$105M Sell
450,758
-2,809
-0.6% -$646K 1.77% 9
2024
Q3
$100M Buy
453,567
+49,027
+12% +$10.1M 1.74% 9
2024
Q2
$79.5M Buy
+404,540
New +$83.6M 1.45% 10

Other funds holding CME

J. Safra Sarasin Holding's CME Position: Q1 2026 in Review

J. Safra Sarasin Holding increased its CME Group (CME) stake by 0.64% in Q1 2026, buying an estimated $715K and bringing the position to 379,013 shares worth $112M. The position accounts for 1.91% of the portfolio, ranked #9.

J. Safra Sarasin Holding first reported a position in CME in Q2 2024 and has held it in 8 quarters since. The position peaked at $134M in Q2 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • J. Safra Sarasin Holding held 379,013 shares of CME Group worth $112M as of Q1 2026.
  • J. Safra Sarasin Holding bought 2,408 CME Group shares in Q1 2026, an estimated $715K.
  • CME Group made up 1.91% of J. Safra Sarasin Holding's portfolio in Q1 2026, its #9 holding.
  • J. Safra Sarasin Holding first reported a position in CME Group in Q2 2024 and has held it in 8 quarters since.
  • J. Safra Sarasin Holding's CME Group position peaked at $134M in Q2 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q1 2026, filed 4 May 2026.